Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

109.30 +3.21 (+3.03%)

Official Closing Price Updated: 7:00 PM EST, Jan 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

52 53 Next >

Jim Cramer Says 'Keep Owning' This Energy Stock, Abbott Laboratories 'Legal Stuff' Is Behind Them ↗

December 11, 2024

Jim Cramer discusses Occidental Petroleum, Cooper Companies, Energy Transfer, Abbott, Kinder Morgan, Advanced Drainage and Archer Aviation.

Via Benzinga

“Cardiol Therapeutics (NASDAQ: CRDL) Heart Health Innovation – AVCO, GXAI, UPC, and More Stocks Driving Groundbreaking Advances”

December 06, 2024

Via AB Newswire

Peering Into Abbott Laboratories's Recent Short Interest ↗

December 06, 2024

Via Benzinga

ABBOTT LABORATORIES (NYSE:ABT) Technical Analysis observations. ↗

December 02, 2024

Will ABBOTT LABORATORIES breakout?

Via Chartmill

2 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income ↗

November 26, 2024

Via The Motley Fool

Analyst Ratings For Abbott Laboratories ↗

November 05, 2024

Via Benzinga

Abbott Surges After Avoiding Another 'Eye-Popping' Verdict In Baby Formula Trial ↗

November 01, 2024

Lawyers for the plaintiff had been arguing for a $6.2 billion verdict.

Via Investor's Business Daily

P/E Ratio Insights for Abbott Laboratories ↗

October 22, 2024

Via Benzinga

ABBOTT LABORATORIES (NYSE:ABT) Reveals Intriguing Technical Aspects. Here's What You Need to Know. ↗

November 25, 2024

Exploring ABBOTT LABORATORIES's Technical Signals and Breakout Potential.

Via Chartmill

2 Dividend Kings to Buy for a Lifetime of Passive Income ↗

November 22, 2024

Via The Motley Fool

What To Do After The Worst Week For Healthcare Stocks Since March 2020? ↗

November 19, 2024

The market was quiet today but we should still expect some gains through year -end albeit a bit choppy.

Via Talk Markets

Plant-Based API Market Poised To Hit $52 Billion By 2034, Driven By Psychedelics And Cannabinoids ↗

November 15, 2024

Via Benzinga

3 Ultra-Safe Dividend Stocks That Have Been Paying Dividends for More Than 100 Years ↗

November 14, 2024

These are income stocks you can buy and hold forever.

Via The Motley Fool

Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues ↗

November 08, 2024

Shares soared out of a buy zone after beating third-quarter forecasts and raising its outlook for 2024.

Via Investor's Business Daily

Is Abbott Laboratories Stock a Buy? ↗

October 17, 2024

The healthcare stock is lagging the market this year.

Via The Motley Fool

2 Dividend Kings That Would Have Doubled Your Money in 5 Years ↗

November 08, 2024

You can be a little greedy sometimes and find great stocks that possess solid growth prospects and also pay dividends.

Via The Motley Fool

Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever ↗

November 08, 2024

You'll also like these stocks for their track record of earnings growth.

Via The Motley Fool

What You Missed On Wall Street This Past Friday ↗

November 03, 2024

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.

Via Talk Markets

AbbVie’s Dividend Isn’t As Scary As It Looks ↗

October 30, 2024

AbbVie currently pays shareholders a quarterly dividend of $1.55 per share, which gives the stock a 3.3% yield on the current price.

Via Talk Markets

These Are The Top Health Stocks to Own for Buy-and-Hold Investing

October 30, 2024

The stocks on this list are the top three buy-and-hold stocks in healthcare, producing significant value for shareholders while leading their respective fields.

Via MarketBeat

3 Dividend Growth Stocks You Can Buy and Hold Forever ↗

October 26, 2024

These healthcare stocks have fantastic dividend track records.

Via The Motley Fool

Beat the Nasdaq With This Cash-Gushing Dividend Stock ↗

October 23, 2024

The company is performing well despite recently losing its biggest growth driver.

Via The Motley Fool

Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever ↗

October 19, 2024

These companies' longtime shareholders have generally been rewarded.

Via The Motley Fool

MarketBeat Week in Review – 10/14 - 10/18

October 19, 2024

Stocks struggled for direction, but the trend before tech earnings is still bullish. Nevertheless, investors should expect volatility ahead of the election.

Via MarketBeat

Topics Artificial Intelligence Economy

Stock Market Rally At Highs; Taiwan Semi, ASML, Netflix In Focus: Weekly Review ↗

October 18, 2024

The Dow Jones and S&P 500 hit highs as they extended weekly win streaks.

Via Investor's Business Daily

Topics Stocks

3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right Now ↗

October 18, 2024

These stocks could deliver big over the long term.

Via The Motley Fool

Abbott Labs Path to Double-Digit Earnings Growth In 2025? This Analyst Is Optimistic ↗

October 17, 2024

Abbott Laboratories reported Q3 sales of $10.64 billion, driven by 8.2% organic growth in medical devices. Adjusted EPS for 2024 projected at $4.64-$4.70, with expectations of double-digit growth...

Via Benzinga

These Analysts Increase Their Forecasts On Abbott Laboratories After Better-Than-Expected Q3 Earnings ↗

October 17, 2024

Via Benzinga

AbbVie Is Doing 'Very Well' But Jim Cramer's Favorite? Abbott Laboratories ↗

October 17, 2024

AbbVie Inc., which split from Abbott Laboratories remains more than a decade ago, is doing "very, very well," Jim Cramer says.

Via Benzinga

Meta To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Thursday ↗

October 17, 2024

Via Benzinga

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

52 53 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.